Malik Vikram
Insider CIK 1730123 · EOLS Director · AEON 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EOLS Evolus, Inc. | A Award | 2026-02-17 | 2026-02-19 | 45,559 | — | $0 | 321,109 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 11,146 | — | $0 | 11,146 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2025-03-07 | 2025-03-11 | 7,364 | — | $0 | 253,878 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 7,500 | $12.96 | $97.2K | 246,514 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2024-05-13 | 2024-05-15 | 28,000 | $12.93 | $362.0K | 254,014 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2024-02-07 | 2024-02-09 | 9,377 | — | $0 | 9,377 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2024-02-07 | 2024-02-09 | 6,464 | — | $0 | 282,014 | SEC↗ |
| EOLS Evolus, Inc. | P Buy | 2023-08-15 | 2023-08-15 | 174,967 | $7.41 | $1.30M | 275,550 | SEC↗ |
| EOLS Evolus, Inc. | J Other | 2023-08-11 | 2023-08-15 | 22,998 | — | $0 | 100,583 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 77,453 | — | $0 | 77,453 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 7,765 | — | $0 | 7,765 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 21,974 | — | $0 | 21,974 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 19,800 | — | $0 | 19,800 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 21,198 | — | $0 | 21,198 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 38,824 | — | $0 | 38,824 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 38,824 | — | $0 | 38,824 | SEC↗ |
| AEON AEON Biopharma, Inc. | A Award deriv | 2023-07-21 | 2023-07-26 | 5,280,000 | — | $0 | 0 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion deriv | 2023-07-21 | 2023-07-26 | 6,900,000 | — | $0 | 0 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion | 2023-07-21 | 2023-07-26 | 89,163 | — | $0 | 6,989,163 | SEC↗ |
| AEON AEON Biopharma, Inc. | C Conversion | 2023-07-21 | 2023-07-26 | 6,900,000 | — | $0 | 6,900,000 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 11,789 | — | $0 | 11,789 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2023-01-27 | 2023-01-31 | 8,293 | — | $0 | 77,585 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2022-01-24 | 2022-01-26 | 22,727 | — | $0 | 22,727 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2022-01-24 | 2022-01-26 | 15,568 | — | $0 | 69,292 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-23 | 2021-08-25 | 26,077 | $11.00 | $286.8K | 1,143,701 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-20 | 2021-08-20 | 49,878 | $10.61 | $529.2K | 1,169,778 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-19 | 2021-08-20 | 11,962 | $10.50 | $125.6K | 1,219,656 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-18 | 2021-08-19 | 25,000 | $10.44 | $261.0K | 1,231,618 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-17 | 2021-08-19 | 42,083 | $10.06 | $423.4K | 1,256,618 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2021-03-26 | 2021-03-26 | 18,011 | — | $0 | 53,724 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2021-02-05 | 2021-02-09 | 19,313 | — | $0 | 35,713 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2020-01-23 | 2020-01-24 | 23,458 | — | $0 | 23,458 | SEC↗ |
| EOLS Evolus, Inc. | P Buy | 2019-06-03 | 2019-06-04 | 1,298,701 | $19.25 | $25.00M | 1,298,701 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2019-01-23 | 2019-01-25 | 14,500 | — | $0 | 14,500 | SEC↗ |
| EOLS Evolus, Inc. | P Buy | 2018-12-17 | 2018-12-17 | 7,800 | $13.04 | $101.7K | 16,400 | SEC↗ |
| EOLS Evolus, Inc. | P Buy | 2018-06-14 | 2018-06-15 | 8,600 | $28.88 | $248.4K | 8,600 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2018-04-24 | 2018-04-26 | 9,086 | — | $0 | 9,086 | SEC↗ |